๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

REVIEW OF THE DEVELOPMENT OF CYANATE AS A DRUG IN THE TREATMENT OF SICKLE CELL ANEMIA

โœ Scribed by Anthony Cerami

Book ID
114881069
Publisher
John Wiley and Sons
Year
1974
Tongue
English
Weight
335 KB
Volume
241
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Rituximab as an effective treatment of h
Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia
โœ Claude Bachmeyer; Jacqueline Maury; Antoine Parrot; Dora Bachir; Katia Stankovic ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 58 KB ๐Ÿ‘ 2 views

To the Editor: Erythrocytapheresis is an established therapy for the prevention of stroke in sickle cell disease [1]. We report its use in the prevention of recurrent acute coronary syndromes. A 50-year-old woman, with homozygous sickle cell disease presented in December 2005 with central chest pai

Use of erythrocytapheresis in the treatm
Use of erythrocytapheresis in the treatment of patients with sickle cell anemia
โœ Dr. Steven H. Kleinman; Carole G. Hurvitz; Dennis Goldfinger ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 651 KB

We perfornied exchange transfusions. utilizing the technique of automated crythrocytaphcresk. for the treatment of patients with sickle cell anemia. In an attempt to determine guideline5 for the use of erythrocytapheresis, we studied the use of this procedure i n three distinct clinical situations i